Reuters logo
Nobel Biocare fourth-quarter results fall short of poll
February 18, 2014 / 5:57 AM / in 4 years

Nobel Biocare fourth-quarter results fall short of poll

ZURICH, Feb 18 (Reuters) - Swiss dental implant maker Nobel Biocare expects to grow sales and improve profitability this year as it posted fourth-quarter earnings that missed forecasts.

Fourth-quarter sales rose 3.9 percent at constant exchange rates to 149.6 million euros ($205 million), generating net profit of 12.4 million euros, compared to 11.8 million a year earlier.

Analysts in a Reuters poll had forecast sales of 156 million and net profit of 13.2 million on average.

The Swiss company said it expects revenue to grow around 3 to 4 percent this year at constant exchange rates and to improve its earnings before interest and tax (EBIT) margin by about 100 basis points. ($1 = 0.7298 euros) (Reporting by Caroline Copley)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below